Robert Moretti
Novartis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert Moretti.
Bioorganic & Medicinal Chemistry Letters | 1999
Yves Auberson; Pierre Acklin; Serge Bischoff; Robert Moretti; Silvio Ofner; Markus Schmutz; Siem Jacob Veenstra
N-Substituted 5-aminomethylquinoxalinediones containing carboxy or phosphonic acids yield potent and selective AMPA and/or NMDA (glycine-binding site) antagonists. Phosphonic acid derivatives are particularly water-soluble and display potent anticonvulsant effects in the electroshock-induced convulsion assay in mice.
Bioorganic & Medicinal Chemistry Letters | 1998
Yves Auberson; Serge Bischoff; Robert Moretti; Markus Schmutz; Siem Jacob Veenstra
A series of 5-aminomethylquinoxaline-2,3-diones have been identified as potent and selective AMPA antagonists. Some of these compounds are also active at the glycine-binding site of the NMDA receptors. A number of these novel, water-soluble quinoxaline-2,3-dione derivatives display protective effects in the electroshock-induced convulsion model in mice.
Bioorganic & Medicinal Chemistry Letters | 2002
Yves Auberson; Hans Allgeier; Serge Bischoff; Kurt Lingenhoehl; Robert Moretti; Markus Schmutz
Archive | 1995
Robert Moretti; Kaspar Zimmermann
Archive | 1996
Pierre Acklin; Hans Allgeier; Yves Auberson; Michel Biollaz; Robert Moretti; Silvio Ofner; Siem Jacob Veenstra
Archive | 1996
Pierre Acklin; Hans Allgeier; Yves Auberson; Michel Biollaz; Robert Moretti; Silvio Ofner; Siem Jacob Veenstra
Archive | 1996
Robert Moretti; Hans Allgeier
Archive | 1995
Robert Moretti; Kaspar Zimmermann
Archive | 2006
Ikubaru Abuuru; Noritoshi Dan; Robert Moretti; Junji Otani; Hiroshi Yamamoto; イクバル アブール; モレッティ ロベルト; 紀寿 團; 淳司 大谷; 宏 山本
Archive | 1996
Pierre Acklin; Hans Allgeier; Yves Auberson; Michel Biollaz; Robert Moretti; Silvio Ofner; Jacob Veenstra